-
effectivehealthcare.ahrq.gov/products/rare-diseases-outcomes/executive
July 24, 2014 - Fifth Journal Supplement on Research Methods: Patient-Centered Health Outcomes in Rare Diseases
Executive Summary July 24, 2014
In April 2013, AHRQ issued a call to authors for abstracts describing original research or systematic reviews on methodologies for studying patient-centered health outcomes in …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear-nomination-140925.pdf
March 20, 2014 - CER 22 Rotator Cuff Tears NSD clean
ntervention
Comparative Effectiveness of
Non-operative and Operative Treatments for
Rotator Cuff Tears
…
-
effectivehealthcare.ahrq.gov/products/c-diff-infections/research-protocol
May 24, 2010 - Current Page Topic Timeline Mar. 10, 2008 Topic Suggestion May. 24, 2010 Research Protocol Dec. 19, 2011 Systematic Review May. 2, 2012 Disposition of Comments Report Sep. 25, 2014 Surveillance Report Effectiveness of Screening and Treatment of C. difficile Infections
Research Protocol Archived May 24, 2010 Downlo…
-
effectivehealthcare.ahrq.gov/products/pressure-ulcer-treatment/research-protocol
November 08, 2011 - Current Page Topic Timeline Sep. 22, 2010 Topic Suggestion Nov. 8, 2011 Research Protocol May. 8, 2013 Systematic Review Sep. 12, 2013 Disposition of Comments Report Pressure Ulcer Treatment Strategies: A Comparative Effectiveness Review
Research Protocol Archived November 8, 2011 Download Main Document PDF 251.7 …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
June 01, 2013 - study designs and outcomes reported were similar
and the population in the study was broad (e.g., not factor
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-heart_research-protocol.pdf
April 18, 2012 - Evidence-based Practice Center Systematic Review Protocol
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Strategies To Improve Cardiovascular Risk Factors in People With Serious
Mental Illness: A Comparative Effectiveness Review
Amendment Date(s):
Amendment 1 – January 20, 20…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_executive.pdf
September 01, 2014 - are at high risk
of having or developing pancreatic adenocarcinoma
(family history or genetic risk factor
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-206-evidence-summary-sodium-potassium.pdf
June 01, 2018 - A primary risk
factor for CVD (cardiovascular disease),
stroke, and other circulatory diseases
is … However, the role of excess dietary sodium
as a major risk factor for HTN has been
supported by large … medications
usually did not control for the class of medication,
thus potentially introducing a confounding factor
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
September 25, 2013 - scientific support for the premise that high on
treatment platelet reactivity (HTPR) is a modifiable risk factor … After adjustment for clinical and procedural risk factors, platelet
reactivity is an independent risk factor … their effect only through
influence on phenotype, and the CYP2C19 loss‐of‐function
genotype is a risk factor
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_overview.pdf
December 19, 2012 - CER 19 Update Core Needle_Open Surgical Biopsy Breast Lesions NSD FINAL
§ Com…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-transitions-of-care-disposition-120504.pdf
October 01, 2011 - Affiliation Section Comment Response
Peer Reviewer #5 Results In Joubert, were intermediate outcomes (risk factor … The Joubert studies did report intermediate
outcomes (risk factor management of blood
pressure, cholesterol … We acknowledge that education and risk factor
modification are also important in both patient populations
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/survival-quality_research.pdf
April 01, 2013 - To date, the FDA has rarely used PRO data as a factor in drug approvals or labeling for
patients with … + cap 54 (26-80);
cap alone 51 (28-83)
BSC = best supportive care; HER2 = human epidermal growth factor … Although the use
of QOL as a prognostic factor for PFS is not the focus of this methods project, there … Correlation between development of rash and efficacy in patients treated with the
epidermal growth factor … Hawkins
Level: 2, State: Excluded
Refid: 1307, Health-related quality of life as prognostic factor
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
November 22, 2011 - Systematic review: Anti-epidermal
growth factor receptor treatment effect modification by KRAS mutations
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tinnitus_executive.pdf
August 01, 2013 - show statistical differences between
groups, but limited statistical power is likely an important
factor
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
March 01, 2016 - Effective
Health Care
Effective Health Care Program
2
Although the primary risk factor for gout … 1,630
o Not gout diagnosis or management or does not address key
question: N=2,716
o Study of risk factor … N=26
o Not gout diagnosis or management or does not address key question:
N=154
o Study of risk factor … urate-lowering impact of
weight loss among men with a high cardiovascular risk profile:
the Multiple Risk Factor … Starting dose is a risk
factor for allopurinol hypersensitivity syndrome: a proposed
safe starting
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd_research-protocol.pdf
August 10, 2010 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: August 10, 2010
Evidence-based Practice Center Systematic Review Protocol
Project Title: Attention Deficit Hyperactivity Disorder:
Effectiveness of Treatment in At-risk Preschoolers; Long…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-priorities_research.pdf
September 01, 2011 - Measurement of this factor should be part of the evaluation
of treatment outcomes. … Measurement of this factor should be part of
evaluation of treatment outcomes. (20)
• R Idea12.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
May 01, 2013 - contaminated
water).3
While there are several causes of HCC, etiology is not
an independent prognostic factor … The setting in which treatment
occurs is a potential factor in the outcomes of local hepatic
therapy
-
effectivehealthcare.ahrq.gov/products/antiplatelet-treatment/research-protocol
November 22, 2011 - Systematic review: Anti-epidermal growth factor receptor treatment effect modification by KRAS mutations
-
effectivehealthcare.ahrq.gov/products/fecal-incontinence/research-protocol
December 01, 2014 - Current Page Topic Timeline Jul. 27, 2012 Topic Suggestion Dec. 1, 2014 Research Protocol Mar. 21, 2016 Systematic Review Treatments for Fecal Incontinence
Research Protocol Archived December 1, 2014 Download Main Document PDF 973.8 KB
Archived: This report is greater than 3 years old. Findings may b…